Charting the SH2 pool

September 13, 2012

New research published in BioMed Central's open access journal Cell Communication and Signaling describes a large set of interactions (interactome) which maps the range of phosphotyrosine (pTyr)-dependent interactions with SH2 domains underlying insulin (Ins), insulin-like growth factor-1 (IGF-1) and fibroblast growth factor (FGF) signaling pathways.

In the control of SH2 domains can be thought of as a master connector and tyrosine kinases the switch. SH2 domains interact with phosphorylated tyrosine containing peptides on receptors and other signaling molecules and couple the to the next protein in the signaling chain.

The contains 111 SH2 domain containing proteins which bind to activated protein tyrosine kinases (PTK). These cell signaling pathways are involved in and their mis-regulation is implicated in a wide range of cancers, immunodeficiences and even diabetes.

A panel of 50 SH2 domains was screened for binding against a set of 192 human phosphotyrosine from the FGF and Ins/IGF-1 pathways and found an extensive interactome consisting of over 500 interactions, most of which are novel.

The pool also highlighted the selectivity of individual SH2 domains. Six general classes of SH2 domain specificity were found which demonstrate not only the evolutionary similarities between SH2 domains in the same family of proteins but across families as well. The study also found subtle differences which could potentially control specificity.

Dr Piers Nash, from The University of Chicago, who led this study observed, "Our study of pTyr binding by SH2 domains is a valuable insight into the selectivity that underpins complex signaling networks. Understanding these signaling systems is a vitally important step towards explaining pathologies such as diabetes and cancer, as well as normal physiology and development."

He continued, "Every cell in our body is an immensely powerful computational device capable of integrating millions of factors and responding with remarkable fidelity. What lies beneath this computational power is not static wires, but dynamic interactions that leverage a finite number of genes to generate an almost infinite number of combinatorial interactions between the protein components that are at the heart of cellular signaling. Mapping the immensely complex set of interactions between the parts laid out by the genetic code represents a next frontier for biomedical science. "

Explore further: Combination therapies for drug-resistant cancers

More information: SRC Homology 2 Domain Binding Sites in Insulin, IGF-1 and FGF receptor mediated signaling networks reveal an extensive potential interactome Bernard A Liu, Brett W Engelmann, Karl Jablonowski, Katherine Higginbotham, Andrew B Stergachis and Piers D Nash, Cell Communication and Signaling (in press)

Related Stories

Combination therapies for drug-resistant cancers

October 10, 2011
Some cancers can be effectively treated with drugs inhibiting proteins known as receptor tyrosine kinases, but not those cancers caused by mutations in the KRAS gene. A team of researchers led by Jeffrey Engelman, at Massachusetts ...

Plant flavonoid luteolin blocks cell signaling pathways in colon cancer cells

January 23, 2012
Plant flavonoid luteolin blocks cell signaling pathways in colon cancer cells

Researchers identify drivers of sarcoma growth and survival

May 2, 2012
To better understand the signaling pathways active in sarcomas, researchers at Moffitt Cancer Center used state-of-the-art mass spectrometry-based proteomics to characterize a family of protein enzymes that act as "on" or ...

Recommended for you

Want to win at sports? Take a cue from these mighty mice

July 20, 2017
As student athletes hit training fields this summer to gain the competitive edge, a new study shows how the experiences of a tiny mouse can put them on the path to winning.

'Smart' robot technology could give stroke rehab a boost

July 19, 2017
Scientists say they have developed a "smart" robotic harness that might make it easier for people to learn to walk again after a stroke or spinal cord injury.

Engineered liver tissue expands after transplant

July 19, 2017
Many diseases, including cirrhosis and hepatitis, can lead to liver failure. More than 17,000 Americans suffering from these diseases are now waiting for liver transplants, but significantly fewer livers are available.

Lunatic Fringe gene plays key role in the renewable brain

July 19, 2017
The discovery that the brain can generate new cells - about 700 new neurons each day - has triggered investigations to uncover how this process is regulated. Researchers at Baylor College of Medicine and Jan and Dan Duncan ...

New animal models for hepatitis C could pave the way for a vaccine

July 19, 2017
They say that an ounce of prevention is worth a pound of cure. In the case of hepatitis C—a disease that affects nearly 71 million people worldwide, causing cirrhosis and liver cancer if left untreated—it might be worth ...

Omega-3 fatty acids fight inflammation via cannabinoids

July 18, 2017
Chemical compounds called cannabinoids are found in marijuana and also are produced naturally in the body from omega-3 fatty acids. A well-known cannabinoid in marijuana, tetrahydrocannabinol, is responsible for some of its ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.